SQALE is a biopharmaceutical company that utilizes quantum-enhanced optimization and a modular biomanufacturing platform to address the high costs and inefficiencies in the production of lifesaving biomolecules. Their approach enables scalable and decentralized manufacturing, improving the accessibility of treatments for cancers, neurological disorders, and infectious diseases.
Funding
$540K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current biomanufacturing processes for life-saving biomolecules face challenges related to high costs, inefficiencies, and reliance on large-scale, fixed facilities. These factors limit the scalability and accessibility of critical treatments for diseases such as cancers, neurological disorders, and infectious diseases.
Solution
SQALE is developing a biomanufacturing platform that combines quantum-enhanced optimization, agile pipeline development, and a modular biomanufacturing unit called BioBox to address the limitations of traditional bioprocessing. The BioBox platform enables distributed and scalable biomanufacturing, enhancing the global availability of biopharmaceuticals and in-demand biomolecules. SQALE leverages data-driven biologics manufacturing, integrating quantum generative AI algorithms and generator-enhanced optimization techniques to improve bioprocess scale-up. This approach aims to reduce costs and increase the efficiency of biomolecule production, ultimately improving patient access to essential therapies.
Target Audience
SQALE's primary target audience includes biopharmaceutical companies and research institutions seeking to improve the efficiency, scalability, and accessibility of biomanufacturing processes.
Features
- Modular and mobile BioBox biomanufacturing platform for horizontal scalability and decentralized deployment
- Quantum-enhanced optimization algorithms for improved bioprocess design and scale-up
- Integration of quantum generative AI for data-driven biologics manufacturing
- Agile pipeline development for rapid deployment of new biomanufacturing processes